News

IsoPSA Improves Detection of Clinically Important Cancers

The prostate specific antigen (PSA) has arguably been one of the most successful biomarkers in medical history — defining screening, early detection and surveillance paradigms for prostate cancer for a generation of physicians worldwide. While the PSA protein, a serine protease, is uniquely associated with the prostate gland, screening and early-detection strategies using serum PSA have come under increased scrutiny due to a relatively poor specificity for cancer as well as an inability to differentiate indolent from aggressive disease, which limit the clinical utility of the test. To improve diagnostic precision, attention has turned to the use of analogues such as …

Read the source article at Consult QD

Categories: News

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s